NCT06151587View on ClinicalTrials.gov

A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children

PHASE3RecruitingINTERVENTIONAL
Enrollment

735

Participants

Timeline

Start Date

August 20, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
Myopia
Interventions
DRUG

QLM3004 Concentration 1

"Low dose of QLM3004 Ophthalmic Solution~1 drop in each eye at bedtime"

DRUG

QLM3004 Concentration 2

"Medium dose of QLM3004 Ophthalmic Solution~1 drop in each eye at bedtime"

DRUG

QLM3004 Concentration 3

"High dose of QLM3004 Ophthalmic Solution~1 drop in each eye at bedtime"

OTHER

Placebo

Vehicle

Trial Locations (1)

Unknown

RECRUITING

The Affiliated Eye Hospital of Wenzhou Medical University, Wenzhou

All Listed Sponsors
lead

Qilu Pharmaceutical Co., Ltd.

INDUSTRY